Judicial evaluation of medical consent for patients with impaired decision-making capacity in Japan: a retrospective observational study of court decisions and ethical implications Authors: Masayuki Ohira, Satoru Makita, Takashi Osada, Masaki Takao Published: 2026 ABSTRACT AbstractBackgroundAdvance care planning and respect for patient autonomy are central concerns in contemporary medical ethics, particularly for patients whose decision-making capacity may be impaired. This study aimed to examine and identify ethical challenges in judicial judgments in Japan relating to these patients.MethodsWe conducted a retrospective observational study of Japanese civil court judgments using Westlaw Japan. We systematically identified judgments addressing physicians’ duties of explanation or informed consent for patients with impaired decision-making capacity. Cases were limited to judgments rendered after May 2007, following publication of the national Guidelines on the Decision-Making Process for Medical Care and Care at the End of Life in Japan. We evaluated five items: (1) substantive consideration of patients’ wishes and values; (2) individualized assessment of decision-making capacity and underlying conditions; (3) whether family members’ wishes were treated merely as surrogate consent; (4) whether a repeated, dialogical decision-making process involving family members and healthcare or care teams was described; and (5) whether advance directives or similar written documents were referenced. Each item was coded dichotomously. We assessed inter-rater agreement between researchers using agreement rates and Cohen’s κ statistics.ResultsOf 116 identified judgments, 10 civil cases met the inclusion criteria. Patients had a mean age of 79.5 years, and all cases involved impaired decision-making capacity due to conditions such as dementia. Courts explicitly attempted to respect or infer patients’ wishes in two cases. Consideration of decision-making capacity and its medical assessment was noted in two cases. In two cases, courts treated family members’ wishes as sources for inferring the patient’s presumed wishes rather than as surrogate consent. A repeated, dialogical decision-making process was described in four cases. No judgment referred to advance directives. Inter-rater agreement was high for all items.ConclusionsThe civil court judgments analyzed in this study for patients with impaired decision-making capacity did not sufficiently reflect principles emphasized in ethical guidelines in Japan. This highlights an important challenge in clinical practice and medico-legal evaluation in Japan and underscores the need for future empirical research to evaluate the implementation of advance care planning in clinical practice.Keywords: Advance care planning, Informed consent, Impaired decision-making capacity, Medical ethics, Surrogate decision-making, Judicial decisions, Medical malpractice litigation, Japan Background In recent years, advance care planning has gained global recognition as an essential approach for respecting patients’ values and preferences, even in situations where decision-making capacity may later become impaired [1, 2]. It is commonly defined as a process that supports individuals in understanding and sharing their values, goals of care, and preferences for future medical treatment, so that future care will remain consistent with their wishes even when they can no longer make decisions themselves [2]. Previous studies have shown that advance care planning contributes to better quality end-of-life care and enhances ethical legitimacy by supporting patient autonomy [3, 4]. In Japan, discussions on withholding or withdrawing life-sustaining treatment have been shaped by several landmark criminal court decisions in the 1990s. These addressed end-of-life care and emphasized the need to explore patients’ presumed wishes when explicit intent could not be established [5, 6]. These decisions highlighted the importance of considering previously expressed wishes, written records such as living wills, and information provided by family members who were familiar with the patient’s values and way of life. After these judgments and related discussions, the Ministry of Health, Labour and Welfare of Japan issued national guidance (Guidelines on the Decision-Making Process for Medical Care and Care at the End of Life) in 2007, which was revised in 2018. This guidance articulates a patient-centered approach to medical decision-making and emphasizes respect for patients’ wishes. These developments are ethically significant in that they seek to safeguard patients’ dignity and autonomy in clinical practice [7]. The guidance does not have formal legal authority under Japanese law, although courts may refer to it as persuasive evidence when evaluating the appropriateness of medical practice [8]. Advance care planning practices are inevitably influenced by national legal frameworks, particularly how surrogate decision-making is defined and evaluated. Previous reports have noted that the legal authority and ethical role of family members or proxies vary substantially across jurisdictions, and that surrogate decisions may not always accurately reflect patients’ own preferences [9]. These concerns are widely recognized as one of the persistent challenges in implementing advance care planning [10, 11]. In Japan, there is substantial uncertainty in clinical practice about how and from whom consent should be obtained when patients have impaired capacity due to conditions such as dementia or disorders of consciousness [12]. Issues related to medical consent are covered in several legal frameworks, and not always addressed consistently. Under the Clinical Trials Act, statutory provisions explicitly identify acceptable surrogate decision-makers for research purposes when it is difficult to obtain informed consent directly from the individual concerned. The Enforcement Regulations under this Act define a “legally authorized representative” as including the research participant’s spouse, a person exercising parental authority, an adult guardian, or other persons in an equivalent position (Enforcement Regulations of the Clinical Trials Act, Article 1, item 8) [13]. In contrast, under Japan’s adult guardianship framework, adult guardians are not explicitly granted comprehensive authority to provide medical consent for routine clinical care. Their legal role as proxy decision-makers for medical treatment therefore remains unclear [14]. Against this institutional background, civil medical malpractice litigation has functioned as a primary forum in which disputes about physicians’ duties of explanation and how medical consent was obtained are evaluated on a case-by-case basis. It is therefore useful to examine court judgments to understand how ethical considerations, including those reflected in advance care planning guidelines, are reflected in judicial evaluations in Japan. In civil litigation, including medical malpractice cases, courts have evaluated physicians’ conduct by considering multiple sources including statutory provisions, accumulated case law, professional standards, governmental guidance, and expert testimony [15]. Previous court decisions are frequently referred to in Japanese judicial reasoning, but do not carry binding precedential authority in the same way as in common law systems. Clinical guidelines are also not given any special legal status as formally binding sources of law, and the relative weight assigned to them is determined by individual judges [16]. Previous empirical research has shown that courts frequently refer to clinical practice guidelines and tend to follow guideline recommendations when evaluating medical negligence claims, effectively treating them as important reference points in judicial decision-making [8]. In Japan, clinicians often face considerable uncertainty about how consent should be obtained when patients have impaired decision-making capacity in the absence of a unified and clearly articulated standard. Given these circumstances, it is necessary to examine how ethical challenges surrounding explanation and consent for patients with impaired decision-making capacity are actually addressed in practice. However, there is little comprehensive empirical research on how explanation and consent for patients with impaired decision-making capacity have been evaluated in Japan since the national guidelines were issued in 2007. Judicial decisions arising from medical malpractice litigation are one of the few publicly accessible and socially authoritative sources for examining real-world conflicts related to medical explanation and consent. Court judgments provide concrete assessments of how physicians’ duties of explanation and consent are evaluated in specific clinical contexts, reflecting the intersection of legal reasoning, medical practice, and ethical principles. Analyzing these judgments offers insights into how patient autonomy, family involvement, and decision-making processes are implicitly or explicitly weighed by the judiciary, providing a unique perspective on the practical operation of ethical norms in Japanese healthcare. This study therefore aimed to systematically examine how Japanese courts have evaluated explanation and consent in cases involving patients with impaired decision-making capacity. By analyzing judicial reasoning in these cases, we sought to explore how ethical considerations related to patient autonomy, family involvement, and decision-making processes are reflected in legal judgments, and to explore the extent of alignment or divergence between ethical ideals articulated in advance care planning guidelines and judicial reasoning in recent Japanese civil malpractice cases. We considered that this approach could provide insights into practical and ethical issues relevant to advance care planning in cases involving impaired decision-making capacity in Japan. The findings may also inform future empirical research on how advance care planning is approached in related Japanese clinical contexts. Methods Study design and sample This study was a retrospective observational study of judicial decisions arising from medical malpractice litigation in Japan. We descriptively analyzed the characteristics of judicial reasoning in judgments that included legal issues about physicians’ duties of explanation and consent for medical treatment involving patients with impaired decision-making capacity. This study was a document-based analysis using publicly available court decisions only and did not involve the collection of new personal information. Ethical approval was therefore not required. Judicial decisions were retrieved using Westlaw Japan, a comprehensive Japanese legal database. We targeted cases arising in clinical settings in which the appropriateness of physicians’ duties of explanation and/or consent for patients with impaired decision-making capacity constituted a disputed legal issue. We searched using predefined combinations of Japanese keywords addressing the following English concepts: (medical consent OR right to self-determination OR duty of explanation) AND (dementia OR decision-making capacity OR impaired capacity OR impaired consciousness OR delirium) AND (end-of-life OR withdrawal of treatment OR life-prolonging treatment OR do-not-attempt-resuscitation (DNAR) OR mechanical ventilation OR gastrostomy OR life-sustaining treatment). These search terms were designed to broadly capture judicial decisions involving medical consent, impaired decision-making capacity, and clinical settings related to end-of-life care. All searches were performed in Japanese in the database but are discussed here in English to ensure transparency and reproducibility for international readers. Retrieved cases were screened by title and full text to identify judgments in which explanation or consent for medical treatment was substantively addressed. To reflect the contemporary ethical and social context in Japan, we limited eligible judgments to those issued in May 2007 or later, when the Ministry of Health, Labour and Welfare first published the Guidelines on the Decision-Making Process for Medical Care and Care at the End of Life [7]. Eligibility criteria Judgments were included for analysis if they met all of the following criteria: the physician’s duty of explanation and the validity of medical consent constituted one of the disputed legal issues concerning medical intervention; the patient was aged 18 years or older and was not subject to parental authority under Japanese law; and the judgment either explicitly described a condition associated with impaired, fluctuating, or potentially reduced decision-making capacity, or, when read as a whole, suggested that the patient’s own participation in explanation and consent was limited, uncertain, or not treated as the primary basis for judicial evaluation, often indicated by the dispute centering on explanations to family members and confirmation of the family’s intentions. For the purposes of this study, we included both cases in which the cause of impaired decision-making capacity was explicitly stated in the judgment, and those involving temporary or fluctuating impairment. This is because, even when the cause or duration of impaired decision-making capacity differs, similar ethical issues may still arise, including whether explanations should be provided directly to the patient, how the patient’s wishes should be inferred, and how family involvement should be positioned in the consent process. We also included cases in which the cause or degree of impairment was not explicitly described, because the aim of the study was not to clinically classify decision-making capacity, but to analyze how courts evaluated explanation and consent in cases where the patient’s decision-making role appeared impaired, fluctuating, or not clearly framed in the judgment. Cases involving people under 18 and judicial decisions in which medical consent was not a substantive issue were excluded from the analysis. Data extraction The following information was extracted from each judgment: date of the judgment and the court, patient sex and age, underlying disease and the clinical condition, type of defendant medical institution (e.g., hospital, clinic, long-term care facility), and whether compensation for breaches of the duty of explanation or consent was awarded, including to whom it was awarded. The selection of eligible cases was first conducted by one investigator who holds both medical and legal qualifications. Two investigators who are qualified attorneys in Japan then independently reviewed the full texts of the judgments and evaluated them against predefined assessment criteria. The reviewers were instructed to base their evaluations solely on the presence or absence of relevant descriptions in the judgments, without assessing the clinical appropriateness or medical validity of the care provided. The assessment considered five items: (1) whether the judgment demonstrated respect for the patient’s own wishes and values when determining the validity of consent, (2) whether the judgment provided an individualized and specific evaluation of diseases or clinical conditions that could affect the patient’s decision-making capacity, (3) whether the judgment refrained from treating family members’ wishes or consent as a simple substitute for the patient’s consent, (4) whether the judgment contained descriptions indicating that family members and healthcare or care teams engaged in repeated discussions to support the patient’s decision-making process, and (5) whether the judgment included descriptions suggesting that advance directives or similar written documents had been prepared in anticipation of the patient’s potential loss of decision-making capacity. Each assessment item was coded as a binary variable (present or absent). Reporting guideline This study was reported in accordance with the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) Statement [17]. To ensure transparency and reproducibility, we have provided detailed descriptions of case selection, coding procedures, and analytic processes. Statistical analysis Continuous variables were expressed as median (interquartile range, 25%–75%), and categorical variables as frequency and percentage. The degree of agreement between researchers was quantified using absolute agreement and Cohen’s kappa. Absolute agreement is the probability that two researchers rate the same points in the same category the same. Cohen’s kappa quantifies the agreement exceeding that owing to chance, and a value of zero indicates agreement by chance. This categorization of chance-corrected agreement was proposed by Landis and Koch: a value of < 0.2 is considered poor agreement, 0.21–0.4 fair, 0.41–0.6 moderate, 0.61–0.8 strong, and > 0.80 near-complete agreement [18]. These measures of inter-rater agreement were calculated using EZR (Saitama Medical Center, Jichi Medical University, Saitama, Japan), a graphical user interface for R (The R Foundation for Statistical Computing, Vienna, Austria) [19]. Results Case selection process We searched Westlaw Japan on December 21, 2025 and identified 116 judicial decisions for consideration. Of these, 48 judgments were issued before May 2007, and were excluded. We also excluded 10 further cases in which issues of explanation or consent in clinical practice were not contested, four involving patients under 18 years old and 39 where the judgments did not, either explicitly or when read as a whole, indicate that impaired or reduced patient decision-making capacity was relevant to the dispute. Five cases were excluded because they included issues of explanation alone, without any dispute about consent. This process left 10 judgments for analysis (Fig. 1). Flow diagram of judicial case selection. Judicial decisions were identified using Westlaw Japan and screened using predefined inclusion and exclusion criteria. Cases were limited to adult patients and judgments in which explanation or consent for medical treatment was a central issue and impairment of decision-making capacity was identifiable. This gave 10 civil court decisions for inclusion in the analysis Characteristics of cases and patients All 10 cases included in the analysis were civil litigation cases (Table 1). Table 1List of judicial decisions included in this studyCaseJudgment dateDistrict CourtCase numberCondition affecting patient’s decision-making capacityDefendantConclusion of the judgment(amount of compensation, Japanese yen)1February 23, 2012Tokyo2009 (Wa) 46,036DementiaHospital and doctorsDismissed2November 17, 2016Tokyo2014 (Wa) 25,447Altered consciousness from a strokeHospitalDismissed3April 10, 2018Osaka2016 (Wa) 7774DementiaHospital and doctorsPartially upheld (1,000,000 yen)4January 25, 2019Chiba2014 (Wa) 1494DementiaClinicPartially upheld (300,000 yen)5May 30, 2019Tokyo2018 (Wa) 13,971DementiaHospitalDismissed6March 19, 2020Asahikawa2016 (Wa) 54DementiaHospitalPartially upheld (1,000,000 yen)7March 18, 2021Tokyo2019 (Wa) 22,881DementiaHospitalDismissed8September 16, 2021Tokyo2018 (Wa) 11,065Delirious stateHospitalDismissed9March 31, 2022Saitama2016 (Wa) 1046Impaired consciousness due to status epilepticusHospitalDismissed10June 19, 2024Tsu2022 (Wa) 107UnknownNursing home for older peoplePartially upheld (1,000,000 yen) List of judicial decisions included in this study The plaintiff was the patient in one case (Case 7), and the patient’s bereaved family members in the other nine cases. In Case 7, the patient had been diagnosed with Alzheimer’s disease, and her child had been appointed as an adult guardian; the lawsuit was therefore filed by the guardian on behalf of the patient. Eight of the patients were women, and sex was not specified in the other two cases. The median patient age was 79.5 years (interquartile range: 72–86 years). Conditions described in the judgments as affecting, or potentially affecting, the patients’ ability to understand explanations and provide consent for medical treatment included dementia in six cases, cerebrovascular disease in one case, delirium in one case, and impaired consciousness in one case. The specific cause was not described in the final case. The defendants consisted of hospitals in eight cases, and the other two cases involved a clinic and a long-term care facility. In two cases, the attending physician was also named as an individual defendant. Judicial assessment of the duty of explanation In two cases (Cases 2 and 8), the judgments contained descriptions indicating efforts to respect and infer the patient’s own wishes or preferences (absolute agreement 100%, Cohen’s κ = 1.00, 95% CI: 1.00–1.00). In two case (Case 2 and 8), the courts attempted to consider and evaluate the degree of the patient’s decision-making capacity and the extent to which the underlying disease or clinical condition affected that capacity (absolute agreement 90%, Cohen’s κ = 0.80, 95% CI: 0.44–1.00). Two cases (Cases 2 and 8) included descriptions suggesting that family members’ wishes or consent were not treated as a simple substitute for the patient’s consent but were instead used to infer the patient’s own wishes (absolute agreement 100%, Cohen’s κ = 1.00, 95% CI: 1.00–1.00). In Case 2, the court, citing a guideline on the decision-making process for end-of-life care, discussed the physician’s duty to provide sufficient explanation to the patient about life-sustaining treatment and to confirm the patient’s wishes. After assessing the degree of recovery of consciousness, however, the court found that the patient was unable to make an autonomous decision about life-sustaining treatment. It further held that the healthcare professionals had not breached their duty to ascertain the views of the family and determine the treatment plan that was best for the patient. In Case 8, the court found that the physician had explained the procedure, necessity, and risks of thoracentesis directly to the patient and that the procedure was medically necessary for her. Although the patient exhibited restless behavior at the time, the court noted that the patient responded to the physician’s explanation by asking her own questions and concluded that the explanation was understandable to her. On this basis, the court rejected the claim of breach of the duty to explain and held that no separate duty arose to provide the same explanation to the patient’s family. Cases 2 and 8 therefore differed from the other judgments in that they more explicitly addressed the patient’s own wishes or capacity for decision-making. In contrast, the other judgments focused mainly on explanations to family members without clearly evaluating the patient’s residual decision-making capacity or clarifying whether family involvement was understood as reflecting presumed wishes, best interests, or family preference. Four judgments (Cases 2, 3, 4 and 10) described processes in which family members and healthcare or care teams engaged in repeated discussions to support the patient’s decision-making (absolute agreement 100%, Cohen’s κ = 1.00, 95% CI: 1.00–1.00). No judgments contained descriptions indicating that advance directives or similar written documents had been prepared (absolute agreement 100%, Cohen’s κ = 1.00, 95% CI: 1.00–1.00). Inter-rater agreement was high across all assessment items. Four of the five items demonstrated perfect agreement (absolute agreement 100%, Cohen’s κ = 1.00, 95% CI: 1.00–1.00), while the remaining item showed substantial agreement (absolute agreement 90%, Cohen’s κ = 0.80, 95% CI: 0.44–1.00). Partially upheld claims and recipients of compensation Compensation for a breach of duty of explanation was awarded in four of the 10 cases (Cases 3, 4, 6, and 10). In these partially upheld cases, the courts consistently focused on whether physicians had fulfilled their duty of explanation toward family members rather than toward the patients themselves. The failure to provide sufficient information to family members was identified as a breach of duty, and none of these judgments treated the adequacy of explanation to the patient as a central issue. The information required in these explanations was the patient’s preoperative clinical course and that surgery would be performed under general anesthesia (Case 3), the risks and disadvantages of gastrostomy (Case 4), the possibility of continued observation instead of surgery (Case 6), and the management plan for end-of-life care (Case 10). In three cases (Cases 3, 4, and 10), the judgments contained descriptions suggesting that medical decisions had been discussed repeatedly among family members over time. While compensation was primarily awarded to the patients, in Case 6 the court awarded damages to a family member on the basis that the family member’s right to self-determination had been infringed. In the cases in which the claims were dismissed, the presence or absence of a duty of explanation toward family members also constituted the central focus of judicial assessment. In several cases (Cases 1, 2, and 7), a breach of duty was denied on the grounds that sufficient explanation had been provided to family members. In another case (Case 5), the court found that there was no legal obligation to provide explanations to or obtain consent from family members. In Case 8, the court held that the patient retained the ability to understand the explanation, and it was therefore sufficient that an explanation had been provided to them, with no explanation required to family members. In Case 9, a breach of the duty of explanation was recognized, but the claim was dismissed because of the absence of a causal relationship between the breach and the alleged harm. These findings suggest that the difference between partially upheld and dismissed claims did not lie simply in whether explanation was contested, but whether the court regarded the omitted explanation as legally material to family involvement in treatment decision-making and whether the breach was linked causally to the alleged harm. Discussion In this study, we systematically collected and analyzed judgments from medical malpractice litigation cases in Japan that addressed issues of explanation and consent for patients with impaired decision-making capacity, then examined their characteristics from an ethical perspective. Our findings suggest recurrent patterns in how Japanese civil malpractice judgments have evaluated explanation and consent for patients with impaired decision-making capacity. To the best of our knowledge, no previous study in Japan has comprehensively examined these issues from an ethical perspective based on court judgments. In other countries, studies have analyzed court cases and policy documents to explore decision-making capacity, surrogate decision-making, and the implementation of advance care planning [9, 20]. However, investigations that consider the legal framework and medical culture in Japan remain relatively limited. This study is therefore positioned as an attempt to fill this gap by examining how ethical considerations about explanation and consent for patients with impaired capacity are reflected in Japanese court judgments. In cases in which claims were partially upheld, judicial reasoning did not appear to explicitly incorporate core elements of advance care planning, such as individualized assessments of patients’ decision-making capacity or efforts to infer patients’ own wishes while avoiding the treatment of family preferences as a simple substitute for patient consent. Nevertheless, these cases shared a notable feature: the presence of ongoing and repeated discussions among family members about medical decisions. This pattern suggests that, in these cases, courts may have focused less on the patient’s residual autonomy than on whether medical institutions were sufficiently responsive to the process through which family members formed and communicated their views. This may indicate that, in these judgments, the award of non-pecuniary damages was linked to a perceived failure to engage adequately with a family-mediated process of decision-making, even in the absence of explicit findings about the patient’s individual decision-making capacity. In this study, in all partially upheld cases and the majority of dismissed cases, the fulfillment of the duty of explanation toward the patient and the degree of the patient’s decision-making capacity were not explicitly examined as central issues. Instead, the adequacy of explanations provided to family members consistently constituted the primary focus of judicial assessment. This suggests that, in the judgments analyzed here, explanation to, and consent from, family members may have functioned in practice as a de facto substitute for explanation to and consent from the patient. The comparison between partially upheld and dismissed claims also suggests that the courts were not concerned simply with whether explanations had been provided in a formal sense, but with whether information regarded as material to family-mediated treatment decision-making had been omitted and whether any breach was causally linked to the alleged harm. In the partially upheld cases, liability was imposed where family members had not been given information that was important for deciding on treatment or care, such as the patient’s clinical course, procedural risks, available alternatives, or the management plan for end-of-life care. Claims were dismissed where the courts found that adequate explanation had already been given to family members, that no legal duty to explain to family members arose, that explanation to the patient was sufficient, or that any breach lacked a causal relationship with the claimed harm. Taken together, these findings suggest that judicial reasoning in these cases centered less on patient-centered informed consent in the strict sense than on the legality of a family-mediated process of explanation and decision-making. We assessed judicial decisions from five perspectives, which were considered closely related to the concept of advance care planning. These perspectives reflect core elements that have repeatedly been emphasized in international theoretical frameworks and empirical research on both advance care planning and decision-making support [2]. Respect for patients’ wishes and values is embedded in the definition of advance care planning, which emphasizes supporting individuals to articulate and share their values and preferences in anticipation of possible future loss of decision-making capacity [2, 21]. Even when patients’ decision-making capacity becomes impaired, ethical guidance consistently stresses the importance of providing care that is aligned as closely as possible with their values and previously expressed preferences [1]. This approach is also consistent with the widely accepted view that respect for autonomy should not be limited to a formal assessment of temporary consent but should encompass the patient’s life narrative and value system formed over time [22]. Recent studies have cautioned against treating family members simply as surrogate decision-makers who automatically substitute for the patient [23, 24]. Instead, family members are increasingly regarded as important sources of information to enable healthcare professionals to infer the patient’s own wishes, values, and preferences [25, 26]. Empirical research has further shown that surrogate decision-making may impose a substantial psychological burden on family members and that surrogate decisions do not always accurately reflect patients’ preferences, underscoring the ethical importance of carefully interpreting family input rather than equating it with patient consent [23]. Finally, a process-oriented understanding of decision-making, which means viewing consent formation as an ongoing, iterative process involving repeated dialogue among patients, families, and healthcare professionals, has been highlighted as a key feature of ethically robust advance care planning practices [4]. This view allows decision-making to be revisited in response to changes in patients’ clinical conditions and evolving values, enhancing ethical legitimacy and responsiveness. Taken together, the five perspectives used in this study are consistent with established international discussions on advance care planning and decision-making support, and similar conceptual elements have been used in at least one previous study [9]. This framework can therefore be regarded as a reasonable analytical framework for examining judicial evaluations of explanation and consent in the Japanese civil malpractice cases analyzed here. To interpret our findings, it is important to clarify the conceptual distinction between the patient’s “inferred wishes” and their “best interests”. Both are common frameworks in surrogate decision-making for patients with impaired decision-making capacity. The former is an estimation of the decision that the patient would have made if they had retained decision-making capacity, based on their previous statements and values. It is therefore understood as an extension of patient autonomy. In contrast, the latter is based on what is considered most beneficial for the patient in their current condition, taking into account medical and welfare perspectives. It does not necessarily rely on the patient’s previously expressed wishes [27]. In the court decisions examined in this study, explanation to and consent from family members often constituted the central focus of judicial evaluation. However, the judgments rarely specified whether family involvement was being treated as reflecting the patient’s inferred wishes, as part of a best-interests determination, or as an independent family preference. In that sense, the judgments did not clearly articulate the normative basis of family involvement. Previous studies on surrogate decision-making in Japan have described interactions between patient wishes, best interests, and family values [28], but the data from this study support a narrower conclusion: in the judicial reasoning examined here, these standards often appeared to coexist without being clearly distinguished [28]. In this study, explanation to and consent from family members were often treated as central, without explicit clarification as to whether they were grounded in inferred patient wishes, best-interests reasoning, or some other normative basis. Case 2 was the exception because it showed that the court first framed the issue in terms of whether the patient should have been adequately informed about life-sustaining treatment and whether the patient’s wishes should have been confirmed, explicitly referring to the guideline on end-of-life decision-making. Only after assessing the patient’s clinical condition and concluding that the patient was unable to make an autonomous decision did the court shift its analysis toward the views of family members and the selection of the treatment plan considered best for the patient. This sequence suggests that, even where the patient’s own wishes were not entirely ignored, judicial reasoning tended to move from a possible concern with the patient’s wishes toward a family-mediated and best-interests-oriented framework once lack of decision-making capacity was recognized. In case 8, the court explicitly evaluated the patient’s decision-making capacity and, upon determining that the patient retained sufficient understanding, held that an explanation to the patient was sufficient and explanation to family members was not required. This was a single case, but important because it contrasts with the pattern observed in the other judgments, in which the adequacy of explanation was assessed primarily in relation to family members. This suggests that, at least in some judgments, the judicial framework remained patient-centered when the patient was regarded as capable of meaningfully understanding the physician’s explanation. By contrast, in the other cases, the judgments rarely focused explicitly on the patient’s own cognitive status or residual decision-making ability. They also did not clearly articulate the normative basis of family involvement, namely, whether family consent or participation was being treated as evidence of the patient’s presumed wishes, part of a best-interests determination, or a preference in its own right. For example, in case 6, the judgment noted that the patient had Alzheimer’s disease and partial disorientation, but focused on the fact that the patient’s brother received the physician’s explanation and made decisions about whether to consent to her surgery. The judgment did not explicitly assess whether the patient had been informed directly, what the content of any explanation to the patient had been, or whether the patient retained sufficient understanding to participate in the decision-making process. Instead, the legal analysis centered on the adequacy of the explanation given to the brother and the validity of his consent. This suggests that, in many of the judgments analyzed here, courts were less concerned with closely examining the patient’s own decision-making participation than evaluating the legality of a family-mediated process of explanation and consent. Cases 2 and 8 also illustrate that the distinction between inferred wishes and best-interests reasoning was handled differently across the cases. In Case 2, the court initially engaged with the patient’s own wishes, but, after concluding that the patient lacked sufficient decision-making capacity, shifted its focus toward the views of family members and the treatment plan considered best for the patient. In Case 8, by contrast, the court explicitly evaluated the patient’s understanding and treated explanation to the patient as sufficient, suggesting that patient-centered reasoning remained possible when the patient was able to understand the explanation. In the remaining cases, the judgments focused mainly on the adequacy of explanation to family members without clearly indicating whether family involvement was understood as reflecting the patient’s presumed wishes, best interests, or family preference. Taken together, these findings suggest that the judgments did not simply fail to distinguish these standards, but rather navigated, prioritized, or conflated them pragmatically depending on the patient’s perceived ability to participate in decision-making and the court’s focus on family-mediated decision-making. Ethical complexity concerns remained in the distinction between family members’ interpretations of the patient’s presumed wishes and the family members’ own independent preferences. In practice, this distinction is not always conceptually or practically straightforward. Previous studies have noted that family members’ views do not necessarily coincide with the patient’s own wishes, but also that family members who know the patient well may sometimes provide valuable insights into the patient’s values and preferences [29]. In Japan, medical decision-making has often been described as a family-centered process, in which family members play an important role in discussions with physicians about treatment decisions [30]. The ethical concept of relational autonomy has been proposed as a framework for understanding how patients’ preferences may be supported and interpreted through close relationships with family members and healthcare professionals [31]. In this study, we therefore focused on how courts positioned family members’ consent in their reasoning, and particularly whether explanations given to family members and consent obtained from them were treated as part of a process of inferring the patient’s wishes, or instead as a relatively straightforward substitute for the patient’s own consent. It can be ethically difficult to draw a strict distinction between these two possibilities, but explanations and consent involving family members should ideally be understood as part of an effort to infer the patient’s own wishes and values [32]. Examining how courts evaluate family involvement in malpractice litigation may therefore provide useful insights into the ethical challenges reflected in these cases around consent for patients with impaired decision-making capacity in Japan. The five assessment elements were not consistently taken into account in the judgments analyzed in this study. In particular, courts tended to treat family members’ consent as a relatively straightforward substitute for the patient’s own consent, without sufficient consideration of the degree of the patient’s remaining cognitive or decision-making capacity. This tendency contrasts with previous reports cautioning against equating family consent with the patient’s own wishes and emphasizing the limits of surrogate decision-making [26]. Fewer than half of the judgments examined explicitly framed decision-making as a continuous process designed to explore the patient’s residual wishes or values over time. This also stands in contrast to the core principles of advance care planning [33]. One possible explanation for this discrepancy is that all the cases included in this study were civil malpractice cases. In Japan, court judgments that explicitly emphasize the need to explore a patient’s presumed wishes in the absence of clear contemporaneous consent have generally been in criminal cases involving end-of-life decision-making [6, 34]. The differences in procedure could therefore have contributed to this discrepancy. More cautiously, the observed gap between ethical guidance and court judgments analyzed here may reflect one feature of how medical consent disputes were addressed in these civil malpractice cases. Ethical guidelines emphasize respect for patients’ wishes and values, whereas civil judgments are designed to resolve legally framed disputes and determine responsibility. In the judgments examined here, procedural clarity and the resolution of disputes may therefore have been prioritized over detailed evaluation of patient-centered decision-making. In the four cases in which claims were partially upheld in this study, there were common features in the judicial reasoning about the adequacy of explanation and consent. The courts did not engage in a detailed or individualized assessment of the patient’s decision-making capacity in any of those cases, and nor did they explicitly attempt to infer the patient’s own wishes or values. Instead, consent obtained from family members was treated as a substitute for the patient’s consent. Advance care planning emphasizes patient-centered decision-making and the interpretation of residual wishes, and these judgments therefore do not appear to fully incorporate its core principles. However, in three of the four partially upheld cases, the judgments contained descriptions suggesting that explanations about medical interventions were provided repeatedly and that discussions with family members were conducted over time. The number of cases examined is limited, but this is a noteworthy characteristic. One possible explanation for this tendency is that all three of these cases arose in the context of terminal care. In end-of-life settings, medical decisions often involve profound uncertainty and value-oriented choices, and repeated explanations and discussions with family members are commonly emphasized in clinical practice. It is therefore plausible that the courts placed particular importance on whether physicians engaged in careful, ongoing communication with family members, even in situations where direct consideration of the patient’s own wishes or decision-making capacity was limited. Nevertheless, from an ethical perspective grounded in advance care planning, this approach leaves room for improvement. The findings suggest that the judgments analyzed here gave greater weight to the process of explanation and deliberation with family members than to explicit efforts to center decision-making on the patient’s own wishes and values. This pattern highlights an ethical challenge reflected in these cases, particularly those involving patients with impaired decision-making capacity. The tendency observed in this study overlaps with challenges discussed in previous ethical and empirical studies on advance care planning in Japan. Previous studies have suggested that advance care planning frameworks grounded in an individualistic interpretation of autonomy may not always be consistent with clinical and sociocultural contexts in which family involvement plays a substantial role [31, 35]. An approach based on relational autonomy is seen as a key component of ethically appropriate advance care planning in Japan [36]. Recent empirical studies and practice-based reports on advance care planning in Japan have also suggested that decision-making processes that respect patients’ wishes while prioritizing dialogue and consensus-building with family members are a pragmatic and culturally embedded approach in Japanese clinical practice [35, 37, 38]. These discussions provide a useful backdrop for interpreting our findings. In the judicial decisions analyzed here, family members’ views were often given substantial legal significance, and explicit consideration of the patient’s own wishes or values remained limited. Our findings are compatible with previous reports describing the importance of family involvement, but they do not establish that judicial reasoning simply mirrors broader clinical norms. Rather, they highlight a possible gap between ethical frameworks that emphasize careful interpretation of the patient’s values and the more family-centered reasoning reflected in these judgments. Our findings underscore the continuing challenge of reconciling respect for patients’ wishes with the prominent role of family members in the cases analyzed. This study has several limitations. First, as in previous studies [39–41], we could not include any cases that were settled before the judicial process started or after filing suit but before judgment, because it was impossible to identify or find these cases. Our findings are therefore limited to cases in which conflicts over medical consent became sufficiently explicit to result in judicial decisions. Second, not all court decisions are publicly available through Westlaw Japan, and selection bias related to publication criteria cannot be excluded. Third, our analysis was based solely on the text of judicial decisions. In Japan, court records can technically be inspected by the public, but access is limited to on-site viewing without copying, rendering original medical records of civil cases impractical for research use and limiting verification of the medical accuracy of judicial factual findings. Fourth, the cases included in this study were clinically heterogeneous in the cause, reversibility, and degree of impaired decision-making capacity of the patient. In some cases, the judgment explicitly described the cause or severity of impairment, and in others, these aspects were only indirectly reflected in the structure of the dispute. We included these cases because they shared core ethical issues related to patient-directed explanation, inference of the patient’s wishes, and the role of family involvement in consent processes. However, differences in the cause, reversibility, and degree of impairment may affect the ethical emphasis of each case. This heterogeneity should therefore be taken into account when interpreting our findings. Conclusion This study clarifies some aspects of how explanation and consent were evaluated in ten Japanese civil medical malpractice judgments, and highlights associated ethical challenges. Elements emphasized in contemporary medical ethics and guidelines—such as respect for patients’ wishes and values, appropriate positioning of family preferences, and attention to decision-making processes—appeared not to be sufficiently reflected in the civil medical malpractice judgments analyzed in this study. The differences between ethical frameworks and judicial reasoning highlighted in this study raise questions for further discussion at the interaction of medico-legal reasoning and clinical ethics in Japan. A small number of judgments explicitly considered the patient’s own wishes or decision-making ability, but this approach remained exceptional. The judicial evaluation of explanation and consent was more often centered on communication with family members and family-mediated decision-making. Acknowledgements This study involved publicly available judicial decisions and did not involve research on human subjects or the collection of new personal data. Ethics approval and consent to participate were therefore not required. Authors’ contributions Masayuki Ohira contributed to the study concept and design, implementation of the study, analysis of the results, and writing of the manuscript. Satoshi Makita and Takashi Osada contributed to implementation of the study. Masaki Takao contributed to critical revision of the manuscript, funding acquisition, administrative support, and supervision. All authors have agreed to the final submitted manuscript. Funding This work was supported by a grant-in-aid from the Research Committee of Prion Disease and Slow Virus Infection from the Ministry of Health, Labour and Welfare [grant number 26FC1011]. Data availability All data analyzed in this study are derived from publicly available court decisions accessed via Westlaw Japan. The datasets used and/or analyzed during the study are available from the corresponding author on reasonable request. Declarations Ethics approval and consent to participate This study involved publicly available judicial decisions and did not involve research on human subjects or the collection of new personal data. Ethics approval and consent to participate were therefore not required. Consent for publication Not applicable — this manuscript does not include individual participant data requiring consent for publication. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement All data analyzed in this study are derived from publicly available court decisions accessed via Westlaw Japan. The datasets used and/or analyzed during the study are available from the corresponding author on reasonable request.